On the track of technological innovation, Unicornshell has captured attention with its strength and innovation. On August 11, Liaoning Unicornshell Pharmaceutical Technology Co., Ltd. stood out in the 14th China Innovation and Entrepreneurship Competition (Liaoning Region), winning first place in the industry category with a high score of 92.22, demonstrating the vibrant momentum of the biomedical industry in Liaoning.

A Benchmark of Technological Innovation in Liaoning
This year's Liaoning regional competition, themed "Gather through Innovation, Move Forward Together", aims to discover and nurture technology enterprises with high growth potential, promoting industrial upgrading and the transformation of old and new growth drivers. The competition covers fields such as next-generation information technology, high-end equipment manufacturing, new materials, and biomedicine, with a fully transparent, fair, and impartial evaluation process.

Unicornshell: Innovation‑Driven, Industry Benchmark
Unicornshell is a technology enterprise dedicated to the R&D, production, and sales of pharmaceutical excipients. Its core products are HPMC empty capsules, including the first‑generation hypromellose (HPMC) capsules and the second‑generation hydroxypropyl starch capsules. Its technology is 3‑5 years ahead of the industry, with over 30 domestic and international invention patents, forming a comprehensive intellectual property protection system.

HPMC capsules, as an important direction for pharmaceutical development, align with the national "14th Five‑Year Plan" for high‑quality pharmaceutical development and the encouragement policies for new excipient R&D in the "Industrial Structure Adjustment Guidance Catalog (2019 Edition)". They fundamentally address the safety risks of traditional gelatin capsules and promote high‑quality development of the pharmaceutical excipient industry. Unicornshell upholds its mission of "promoting medication safety and protecting human health", actively responds to national industrial policies and the rural revitalization strategy, and continuously drives industry innovation and upgrading.

Innovation‑Driven, Empowering Industrial Upgrading
Winning first place this time is a concentrated reflection of Unicornshell's strengths in R&D capability, technological achievements, corporate management, and more. It also marks a solid step forward in promoting intelligent manufacturing and the application of green new materials. In the future, Unicornshell will continue to adhere to the dual‑driver of "technological innovation + market expansion", deepen industry‑university‑research collaboration, strengthen intellectual property protection, build an internationally leading HPMC capsule industry system, and contribute to the high‑quality development of the biomedical industry in Liaoning and across the country.

Future Outlook
As global demand for high‑quality HPMC capsules continues to grow, Unicornshell will leverage the competition platform and policy opportunities to accelerate the implementation of more innovative projects, continuously empower the green pharmaceutical industry chain, and strive to become a global leader in the HPMC capsule industry.